Details of the Drug

General Information of Drug (ID: DMIMJNB)

• Drug Name: MDR-101

Indication

Disease Entry	ICD 11	Status	REF
Kidney transplant rejection	NE84	Phase 3	[1]

• Drug Type: Cell therapy
• Cross-matching ID:
  DrugBank ID: DB18513
  TTD ID: D8D1MI

References

• [1] ClinicalTrials.gov (NCT03363945) Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants. U.S. National Institutes of Health.